Tekla Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $112M | Sell |
|
|||||
|
2023
Q1 | $104M | Hold |
|
|||||
|
2022
Q4 | $95.4M | Buy |
|
|||||
|
2022
Q3 | $90.7M | Sell |
|
|||||
|
2022
Q2 | $102M | Buy |
|
|||||
|
2022
Q1 | $80.6M | Buy |
|
|||||
|
2021
Q4 | $60M | Hold |
|
|||||
|
2021
Q3 | $49.5M | Sell |
|
|||||
|
2021
Q2 | $79.7M | Hold |
|
|||||
|
2021
Q1 | $84.9M | Buy |
|
|||||
|
2020
Q4 | $72.2M | Sell |
|
|||||
|
2020
Q3 | $109M | Sell |
|
|||||
|
2020
Q2 | $139M | Sell |
|
|||||
|
2020
Q1 | $116M | Sell |
|
|||||
|
2019
Q4 | $108M | Buy |
|
|||||
|
2019
Q3 | $82.5M | Sell |
|
|||||
|
2019
Q2 | $89.8M | Buy |
|
|||||
|
2019
Q1 | $81.6M | Buy |
|
|||||
|
2018
Q4 | $70.6M | Buy |
|
|||||
|
2018
Q3 | $78.7M | Sell |
|
|||||
|
2018
Q2 | $98.8M | Sell |
|
|||||
|
2018
Q1 | $100M | Sell |
|
|||||
|
2017
Q4 | $96.5M | Sell |
|
|||||
|
2017
Q3 | $111M | Sell |
|
|||||
|
2017
Q2 | $103M | Sell |
|
|||||
|
2017
Q1 | $113M | Hold |
|
|||||
|
2016
Q4 | $76.1M | Hold |
|
|||||
|
2016
Q3 | $90.1M | Hold |
|
|||||
|
2016
Q2 | $88.9M | Hold |
|
|||||
|
2016
Q1 | $82.2M | Hold |
|
|||||
|
2015
Q4 | $130M | Buy |
|
|||||
|
2015
Q3 | $105M | Buy |
|
|||||
|
2015
Q2 | $111M | Buy |
|
|||||
|
2015
Q1 | $54.8M | Sell |
|
|||||
|
2014
Q4 | $83.4M | Hold |
|
|||||
|
2014
Q3 | $78.8M | Buy |
|
|||||
|
2014
Q2 | $51.2M | Buy |
|
|||||
|
2014
Q1 | $35.3M | Hold |
|
|||||
|
2013
Q4 | $37.1M | Hold |
|
|||||
|
2013
Q3 | $37.9M | Buy |
|
|||||
|
2013
Q2 | $36.3M | Buy |
|